Genentech

RITUXAN

  1. Home
  2.  / 
  3. J Code
  4.  / RITUXAN – J9312

Manufacturer:

Genentech

Name:

RITUXAN

HCPCS Code Descriptor:

Injection, rituximab, 10 mg

Category:

J Code

HCPCS:

J9312

NDC(s):

50242-0053-06, 50242-0051-21

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

50242-0051-10

Please contact us regarding potential compendia errors/discrepancies

About:

RITUXAN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9312 is aligned to the drug RITUXAN.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Inj., rituximab, 10 mg

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Rituxan-Billing-Coding-for-RA.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation

https://www.gene.com/patients/patient-foundation

RITUXAN - J9312